{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T22:49:47Z","timestamp":1648766987749},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/mcg.0b013e31802dc55f","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T16:35:06Z","timestamp":1236098106000},"page":"927-931","source":"Crossref","is-referenced-by-count":1,"title":["Compliance With Referral for Hepatitis C Evaluation Among Veterans"],"prefix":"10.1097","volume":"41","author":[{"given":"Carla W.","family":"Brady","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia J.","family":"Coffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn","family":"Provenzale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210305","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994","volume":"341","author":"Alter","year":"1999","journal-title":"N Engl J Med"},{"key":"R2-11-20210305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2004-832922","article-title":"The natural history of hepatitis C","volume":"24","author":"Afdhal","year":"2004","journal-title":"Sem Liver Dis"},{"key":"R3-11-20210305","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"R4-11-20210305","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Combination of peginterferon alfa-2a plus ribavirin in patients with chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"R5-11-20210305","first-page":"236A","article-title":"Seroepidemiology of hepatitis B and C in an urban VA medical center","volume":"24","author":"Pham","year":"1994","journal-title":"Hepatology"},{"key":"R6-11-20210305","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1572-0241.2000.01854.x","article-title":"Epidemiology of hepatitis C virus infection in American veterans","volume":"95","author":"Cheung","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R7-11-20210305","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1053\/jhep.2001.29303","article-title":"Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration Medical Center","volume":"34","author":"Briggs","year":"2001","journal-title":"Hepatology"},{"key":"R8-11-20210305","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.20502","article-title":"Elevated prevalence of hepatitis C infection in users of United States Veterans Medical Centers","volume":"41","author":"Dominitz","year":"2005","journal-title":"Hepatology"},{"key":"R9-11-20210305","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1572-0241.2002.05439.x","article-title":"Limited success of HCV antiviral therapy in United States Veterans","volume":"97","author":"Cawthorne","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R10-11-20210305","article-title":"Applied logistic regression. 2nd ed","author":"Hosmer","year":"2000"},{"key":"R13-11-20210305","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00004836-200203000-00015","article-title":"A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection","volume":"34","author":"Muir","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"R14-11-20210305","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.mcg.0000123203.36471.70","article-title":"Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C","volume":"38","author":"Rowan","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"R15-11-20210305","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/gast.2002.34750","article-title":"Psychiatric disorders among veterans with hepatitis C infection","volume":"123","author":"El-Serag","year":"2002","journal-title":"Gastroenterology"},{"key":"R16-11-20210305","doi-asserted-by":"crossref","first-page":"288","DOI":"10.7326\/0003-4819-136-4-200202190-00008","article-title":"Surprisingly small effect of antiviral treatment in patients with hepatitis C","volume":"136","author":"Falck-Ytter","year":"2002","journal-title":"Ann Intern Med"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004836-200711000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:18:29Z","timestamp":1618035509000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-200711000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e31802dc55f","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}